RiVive Nasal Spray Gets Priority Review for OTC Treatment of Opioid Overdose
RiVive is an opioid antagonist that reverses the effects of opioids, including respiratory depression, sedation, and hypotension.
RiVive is an opioid antagonist that reverses the effects of opioids, including respiratory depression, sedation, and hypotension.
The resubmitted NDA was in response to a Complete Response Letter issued by the FDA in December 2021.
In a recent social media video challenge, individuals were encouraged to cook chicken in NyQuil or another similar OTC cough and cold medication.
AD04 is a genetically targeted, serotonin-3 receptor antagonist that is believed to reduce alcohol intake by interfering with the dopamine reward system.
Individual consumers are not restricted from having or using JUUL products; however, the Agency will ensure compliance by retailers.
Pharmacodynamic studies have shown that nalmefene has a longer duration of action than naloxone.
Researchers used data from the State Unintentional Drug Overdose Reporting System in order to assess trends in gabapentin-involved overdose deaths.
The Strategy focuses on 2 main drivers of the opioid epidemic: drug trafficking and untreated addiction.
Naloxone Auto-Injector is specifically designed to be a medical countermeasure for military personnel or chemical incident responders against the potential threat of exposure to synthetic opioids on the battlefield.
The FDA defines acute pain as pain, lasting up to 30 days, typically in response to some form of tissue injury, such as trauma or surgery.